Foxo Technologies Inc. FOXOW

Q2 FY2026 · ended Jun 30, 2026 · Revenue $4.72M, -9.6% YoY · Filed Aug 14, 2026

Foxo Technologies Inc. (FOXO) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $4.7 million and net income of $8.1 million. Free cash flow was $293,295. As of Jun 30, 2026 it held $58,409 in cash and investments and $3.4 million in total debt.

Revenue
$4.72M
-9.6% vs year-ago quarter
Net income
$8.14M
+1659.3% vs year-ago quarter
Operating cash flow
$298,674
+112.6% vs year-ago quarter
Free cash flow
$293,295
+150.4% vs prior quarter
EPS
—
Dividend per share
None
Shares outstanding
1.66M
-96.4% vs year-ago quarter
Net cash
$-3.39M
Q2 FY2026
Operating margin
-4.9%
TTM

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
FOXO (OTC), FOXOW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
West Palm Beach, FL
SEC filer status
, Emerging growth company
SEC CIK
1812360
Former names
Delwinds Insurance Acquisition Corp. (until Sep 15, 2022)

Other Services-Commercial Physical & Biological Research companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$4.7M
$5.2M
$4.4M
$3.5M
$5.2M
Operating income
$8.7M
-$276,851
-$8.5M
-$859,821
$567,121
Net income
$8.1M
-$1.5M
-$9.4M
-$1.9M
-$522,021
Operating cash flow
$298,674
-$577,898
-$104,030
-$44,784
-$2.4M
Free cash flow
$293,295
-$581,893
—
—
—
Total assets
$45.9M
$45.8M
$44.6M
$52.1M
$50.0M
Total liabilities
$45.0M
$36.2M
$33.5M
$32.0M
$36.3M
Stockholders' equity
$988,306
$9.7M
$11.1M
$20.2M
$13.7M
Cash and investments
$58,409
$65,896
$207,453
$628,557
$321,789
Total debt
$3.4M
$3.6M
$3.7M
$3.8M
$3.9M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Regulation FD disclosure
Oct 29, 2026 Oct 25, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 14, 2026 Aug 13, 2026
8-K Current report
Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
8-K Current report
Material agreement
Jul 27, 2026 Jul 22, 2026
8-K Current report
Regulation FD disclosure
Jul 6, 2026 Jul 6, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.